To explore the clinical signature of DDX27 in GC, we conducted Kaplan–Meier (KM) analysis and discovered GC patients with a higher DDX27 expression always had worse overall survival (OS) (p < 0.001; Figure 2A). This evidence concerns the gene DDX27 and gastric cancer.